US$ 24.72
semaglutide abuse Weight-loss drugs are becoming more accessible, but are they always safe? Experts raise concerns about the misuse of generics and the risks of unsupervised use. From side effects to long-term impact side effects of drinking alcohol
Description
It demonstrates excellent results in the long run, especially when combined with a balanced diet, proper exercise program, healthy lifestyle habits, and other crucial factors that directly influence ones quality of life
Who Can Benefit from Semaglutide Semaglutide is typically prescribed for individuals with a BMI of 30 or above, or 27 and above if they have at least one weight-related health condition such as high blood pressure, type 2 diabetes, or high cholesterol

Tirzepatide (a GLP-1R/GIPR dual agonist), licensed by the MHRA as Mounjaro for type 2 diabetes and, subject to NICE guidance, for weight management in adults with obesity, achieved mean weight reductions of up to approximately 22% in the SURMOUNT-1 trial (NEJM 2022) a notable improvement over GLP-1R monotherapy

GLP-1 agonist and weight

Panagaki, T., Randi, E